Sec Form 4 Filing - Keane Robert S @ CIMPRESS plc - 2020-02-26

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Keane Robert S
2. Issuer Name and Ticker or Trading Symbol
CIMPRESS plc [ CMPR]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
CEO, Chairman
(Last) (First) (Middle)
CIMPRESS PLC, BUILDING D, XEROX TECHNOLOGY PARK
3. Date of Earliest Transaction (MM/DD/YY)
02/26/2020
(Street)
DUNDALK, COUNTY LOUTH, IRELAND
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 02/26/2020 M 48,400 A $ 47.91 406,964 ( 1 ) I By Eastern Irrevocable, LLC
Ordinary Shares 02/26/2020 M 500,000 A $ 50 906,964 ( 1 ) I By Eastern Irrevocable, LLC
Ordinary Shares 02/26/2020 M 112,231 A $ 50 1,019,195 ( 1 ) I By Eastern Irrevocable, LLC
Ordinary Shares 02/26/2020 F 445,220 ( 2 ) D $ 119.91 573,975 ( 1 ) I By Eastern Irrevocable, LLC
Ordinary Shares 02/26/2020 M 48,400 A $ 47.91 406,924 ( 1 ) I By Western Irrevocable, LLC
Ordinary Shares 02/26/2020 M 500,000 A $ 50 906,924 ( 1 ) I By Western Irrevocable, LLC
Ordinary Shares 02/26/2020 M 112,231 A $ 50 1,019,155 ( 1 ) I By Western Irrevocable, LLC
Ordinary Shares 02/26/2020 F 445,220 ( 2 ) D $ 119.91 573,935 ( 1 ) I By Western Irrevocable, LLC
Ordinary Shares 109,181 I By Keane Family Foundation
Ordinary Shares 28,375 I By RHS Holdings Incorporated
Ordinary Shares 51,900 I By Delaware 2001, LLC
Ordinary Shares 390,000 I By First Delaware 2003, LLC
Ordinary Shares 390,000 I By Second Delaware 2003, LLC
Ordinary Shares 185,000 I By Third Delaware 2011, LLC
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option (right to buy) $ 47.91 02/26/2020 M 48,400 05/06/2011( 3 ) 05/06/2020 Ordinary Shares 48,400 $ 47.91 0 I By The Eastern Irrevocable, LLC
Option (right to buy) $ 50 ( 4 ) 02/26/2020 M 500,000 05/04/2013( 5 )( 6 ) 05/04/2020 Ordinary Shares 500,000 $ 50 0 I By The Eastern Irrevocable, LLC
Option (right to buy) $ 50.0001 ( 4 ) ( 7 ) 02/26/2020 M 500,000 05/04/2013( 5 )( 6 ) 05/04/2020 Ordinary Shares 500,000 $ 50 0 I By The Eastern Irrevocable, LLC
Option (right to buy) $ 47.91 02/26/2020 M 48,400 05/06/2011( 3 ) 05/06/2020 Ordinary Shares 48,400 $ 47.91 0 I By Western Irrevocable, LLC
Option (right to buy) $ 50 ( 4 ) 02/26/2020 M 500,000 05/04/2013( 5 )( 6 ) 05/04/2020 Ordinary Shares 500,000 $ 50 0 I By Western Irrevocable, LLC
Option (right to buy) $ 50.0001 ( 4 ) ( 7 ) 02/26/2020 M 112,231 05/04/2013( 5 )( 6 ) 05/04/2020 Ordinary Shares 112,231 $ 50 0 I By Western Irrevocable, LLC
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Keane Robert S
CIMPRESS PLC
BUILDING D, XEROX TECHNOLOGY PARK
DUNDALK, COUNTY LOUTH, IRELAND
X CEO, Chairman
Signatures
/s/Kathryn L. Leach, as attorney-in fact-for Robert Keane 02/28/2020
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders.
( 2 )Of the 445,220 shares forfeited, 274,626 shares were forfeited as payment of the exercise price and 170,594 shares were forfeited as payment of the withholding taxes.
( 3 )This option became exercisable as to 25% of the original number of shares on the Exercisable Date shown on Table II, and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter.
( 4 )The option exercise price per share is $50.00, which is at least 33% higher than the closing price of Cimpress' ordinary shares on the NASDAQ Global Select Market on the date of grant.
( 5 )The share options vest over a seven-year period as follows: 6.25% of the original number of ordinary shares subject to the share options vest on the Exercisable Date in Table II. The remaining ordinary shares vest on a quarterly basis over the subsequent six years in tranches ranging from 1.56% to 10.94% of the original number of ordinary shares subject to the option.
( 6 )In addition to the vesting restrictions referred to in footnote 5 above, these share options are exercisable only on days when the high price per share of Cimpress' ordinary shares on NASDAQ equals or exceeds $75.00.
( 7 )$0.0001 added to exercise price solely to differentiate the securities on this Form 4.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.